West Pharmaceutical Services (WST) : Kalmar Investments Inc De reduced its stake in West Pharmaceutical Services by 33.55% during the most recent quarter end. The investment management company now holds a total of 966,193 shares of West Pharmaceutical Services which is valued at $72.1 Million after selling 487,885 shares in West Pharmaceutical Services , the firm said in a disclosure report filed with the SEC on May 27, 2016.West Pharmaceutical Services makes up approximately 2.88% of Kalmar Investments Inc De’s portfolio.
Other Hedge Funds, Including , Penobscot Investment Management Company reduced its stake in WST by selling 1,310 shares or 25.94% in the most recent quarter. The Hedge Fund company now holds 3,740 shares of WST which is valued at $272,010. West Pharmaceutical Services makes up approx 0.10% of Penobscot Investment Management Company’s portfolio. Northwestern Mutual Investment Management Company added WST to its portfolio by purchasing 12,479 company shares during the most recent quarter which is valued at $907,598. West Pharmaceutical Services makes up approx 0.02% of Northwestern Mutual Investment Management Company’s portfolio.Chicago Equity Partners boosted its stake in WST in the latest quarter, The investment management firm added 820 additional shares and now holds a total of 12,355 shares of West Pharmaceutical Services which is valued at $885,359. West Pharmaceutical Services makes up approx 0.03% of Chicago Equity Partners’s portfolio. State Of Tennessee Treasury Department added WST to its portfolio by purchasing 20,000 company shares during the most recent quarter which is valued at $1.4 Million. West Pharmaceutical Services makes up approx 0.01% of State Of Tennessee Treasury Department’s portfolio. Carnick Kubik added WST to its portfolio by purchasing 1,000 company shares during the most recent quarter which is valued at $71,660. West Pharmaceutical Services makes up approx 0.04% of Carnick Kubik’s portfolio.
West Pharmaceutical Services opened for trading at $75.39 and hit $76.49 on the upside on Tuesday, eventually ending the session at $76.27, with a gain of 1.18% or 0.89 points. The heightened volatility saw the trading volume jump to 2,71,051 shares. Company has a market cap of $5,574 M.
On the company’s financial health, West Pharmaceutical Services reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.51. The company had revenue of $362.10 million for the quarter, compared to analysts expectations of $356.32 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.
Many Wall Street Analysts have commented on West Pharmaceutical Services. West Pharmaceutical Services was Initiated by Wells Fargo to “Outperform” on Mar 22, 2016.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).